{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T04:10:17Z","timestamp":1763698217739,"version":"3.45.0"},"reference-count":10,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T00:00:00Z","timestamp":1763683200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T00:00:00Z","timestamp":1763683200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Hematopathol"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s12308-025-00669-z","type":"journal-article","created":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T04:06:25Z","timestamp":1763697985000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["A novel IKZF1::FAM3C fusion associated with inversion of chromosome 7, inv(7)(p13q32), in relapsed acute myeloid leukemia"],"prefix":"10.1007","volume":"18","author":[{"given":"Haiming","family":"Tang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mingfei","family":"Yan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanming","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4692-9969","authenticated-orcid":false,"given":"Jinjuan","family":"Yao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,11,21]]},"reference":[{"issue":"12","key":"669_CR1","doi-asserted-by":"publisher","first-page":"2395","DOI":"10.1038\/s41375-023-02061-1","volume":"37","author":"JN Eckardt","year":"2023","unstructured":"Eckardt JN, Stasik S, R\u00f6llig C et al (2023) Mutated IKZF1 is an independent marker of adverse risk in acute myeloid leukemia. Leukemia 37(12):2395\u20132403. https:\/\/doi.org\/10.1038\/s41375-023-02061-1","journal-title":"Leukemia"},{"issue":"9","key":"669_CR2","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.3324\/haematol.2015.124321","volume":"100","author":"JD de Rooij","year":"2015","unstructured":"de Rooij JD, Beuling E, van den Heuvel-Eibrink MM et al (2015) Recurrent deletions of IKZF1 in pediatric acute myeloid leukemia. Haematologica 100(9):1151\u20131159. https:\/\/doi.org\/10.3324\/haematol.2015.124321","journal-title":"Haematologica"},{"issue":"8","key":"669_CR3","doi-asserted-by":"publisher","first-page":"2165","DOI":"10.1007\/s00277-023-05250-1","volume":"102","author":"S Srinivasan","year":"2023","unstructured":"Srinivasan S, Ramanathan S, Kumar S, Peyam S, Radhakrishnan V (2023) Prevalence and prognostic significance of IKZF1 deletion in paediatric acute lymphoblastic leukemia: a systematic review and meta-analysis. Ann Hematol 102(8):2165\u20132179. https:\/\/doi.org\/10.1007\/s00277-023-05250-1","journal-title":"Ann Hematol"},{"issue":"4","key":"669_CR4","doi-asserted-by":"publisher","first-page":"565","DOI":"10.3324\/haematol.2017.185603","volume":"103","author":"R Marke","year":"2018","unstructured":"Marke R, van Leeuwen FN, Scheijen B (2018) The many faces of IKZF1 in B-cell precursor acute lymphoblastic leukemia. Haematologica 103(4):565\u2013574. https:\/\/doi.org\/10.3324\/haematol.2017.185603","journal-title":"Haematologica"},{"issue":"1","key":"669_CR5","doi-asserted-by":"publisher","DOI":"10.1186\/s40164-023-00398-y","volume":"12","author":"X Zhang","year":"2023","unstructured":"Zhang X, Huang A, Liu L et al (2023) The clinical impact of IKZF1 mutation in acute myeloid leukemia. Exp Hematol Oncol 12(1):33. https:\/\/doi.org\/10.1186\/s40164-023-00398-y","journal-title":"Exp Hematol Oncol"},{"issue":"1","key":"669_CR6","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20010228","volume":"20","author":"C Rautenberg","year":"2019","unstructured":"Rautenberg C, Germing U, Haas R, Kobbe G, Schroeder T (2019) Relapse of acute myeloid leukemia after allogeneic stem cell transplantation: prevention, detection, and treatment. Int J Mol Sci 20(1):228. https:\/\/doi.org\/10.3390\/ijms20010228","journal-title":"Int J Mol Sci"},{"issue":"5","key":"669_CR7","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1111\/bjh.20027","volume":"206","author":"S Stasik","year":"2025","unstructured":"Stasik S, Eckardt JN, R\u00f6llig C et al (2025) The IKZF1 N159S mutation is associated with poor outcome and a distinct molecular profile in adult patients with AML. Br J Haematol 206(5):1373\u20131379. https:\/\/doi.org\/10.1111\/bjh.20027","journal-title":"Br J Haematol"},{"key":"669_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.exphem.2016.11.002","volume":"46","author":"ML Churchman","year":"2017","unstructured":"Churchman ML, Mullighan CG (2017) Ikaros: exploiting and targeting the hematopoietic stem cell niche in B-progenitor acute lymphoblastic leukemia. Exp Hematol 46:1\u20138. https:\/\/doi.org\/10.1016\/j.exphem.2016.11.002","journal-title":"Exp Hematol"},{"issue":"13","key":"669_CR9","doi-asserted-by":"publisher","first-page":"1520","DOI":"10.1182\/blood.2019002655","volume":"136","author":"C Song","year":"2020","unstructured":"Song C, Ge Z, Ding Y et al (2020) IKAROS and CK2 regulate expression of BCL-XL and chemosensitivity in high-risk B-cell acute lymphoblastic leukemia. Blood 136(13):1520\u20131534. https:\/\/doi.org\/10.1182\/blood.2019002655","journal-title":"Blood"},{"issue":"1","key":"669_CR10","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-020-00972-5","volume":"13","author":"X Zhang","year":"2020","unstructured":"Zhang X, Zhang X, Li X et al (2020) The specific distribution pattern of IKZF1 mutation in acute myeloid leukemia. J Hematol Oncol 13(1):140. https:\/\/doi.org\/10.1186\/s13045-020-00972-5","journal-title":"J Hematol Oncol"}],"container-title":["Journal of Hematopathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12308-025-00669-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12308-025-00669-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12308-025-00669-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T04:06:26Z","timestamp":1763697986000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12308-025-00669-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,21]]},"references-count":10,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["669"],"URL":"https:\/\/doi.org\/10.1007\/s12308-025-00669-z","relation":{},"ISSN":["1868-9256","1865-5785"],"issn-type":[{"value":"1868-9256","type":"print"},{"value":"1865-5785","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,21]]},"assertion":[{"value":"2 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable. This study is a single case report and does not involve any experimental interventions or prospective data collection.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Written informed consent for publication was obtained from the patient or their legal representative.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Consent for publication was obtained from the patient.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"55"}}